Medical Care
Global Recombinant Human GMF-β Market Research Report 2025
- Mar 11, 25
- ID: 74351
- Pages: 93
- Figures: 100
- Views: 29
The global market for Recombinant Human GMF-β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period.
GMF-beta belongs to the actin-binding ADF/cofilin family of proteins. It contains an ADF-H domain, but crystallographic and NMR studies have shown structural differences between the human and mouse ADF-H domains. It was originally identified as a growth gamma differentiation factor acting on neurons and glial cells. It has also been shown to function intracellularly as a regulator of MAP kinase signaling.
North American market for Recombinant Human GMF-β is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Human GMF-β is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Human GMF-β in University is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Human GMF-β include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human GMF-β, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human GMF-β.
The Recombinant Human GMF-β market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human GMF-β market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human GMF-β companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Segment by Type
Purity＜95%
Purity ≥95%
Segment by Application
University
Research Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human GMF-β company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
GMF-beta belongs to the actin-binding ADF/cofilin family of proteins. It contains an ADF-H domain, but crystallographic and NMR studies have shown structural differences between the human and mouse ADF-H domains. It was originally identified as a growth gamma differentiation factor acting on neurons and glial cells. It has also been shown to function intracellularly as a regulator of MAP kinase signaling.
North American market for Recombinant Human GMF-β is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Human GMF-β is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Human GMF-β in University is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Human GMF-β include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human GMF-β, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human GMF-β.
The Recombinant Human GMF-β market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human GMF-β market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human GMF-β companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Segment by Type
Purity＜95%
Purity ≥95%
Segment by Application
University
Research Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human GMF-β company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human GMF-β Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Market by Application
1.3.1 Global Recombinant Human GMF-β Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 University
1.3.3 Research Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human GMF-β Market Perspective (2020-2031)
2.2 Global Recombinant Human GMF-β Growth Trends by Region
2.2.1 Global Recombinant Human GMF-β Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Human GMF-β Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Human GMF-β Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Human GMF-β Market Dynamics
2.3.1 Recombinant Human GMF-β Industry Trends
2.3.2 Recombinant Human GMF-β Market Drivers
2.3.3 Recombinant Human GMF-β Market Challenges
2.3.4 Recombinant Human GMF-β Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human GMF-β Players by Revenue
3.1.1 Global Top Recombinant Human GMF-β Players by Revenue (2020-2025)
3.1.2 Global Recombinant Human GMF-β Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Human GMF-β Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human GMF-β Revenue
3.4 Global Recombinant Human GMF-β Market Concentration Ratio
3.4.1 Global Recombinant Human GMF-β Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human GMF-β Revenue in 2024
3.5 Global Key Players of Recombinant Human GMF-β Head office and Area Served
3.6 Global Key Players of Recombinant Human GMF-β, Product and Application
3.7 Global Key Players of Recombinant Human GMF-β, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human GMF-β Breakdown Data by Type
4.1 Global Recombinant Human GMF-β Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Human GMF-β Forecasted Market Size by Type (2026-2031)
5 Recombinant Human GMF-β Breakdown Data by Application
5.1 Global Recombinant Human GMF-β Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Human GMF-β Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Human GMF-β Market Size (2020-2031)
6.2 North America Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Human GMF-β Market Size by Country (2020-2025)
6.4 North America Recombinant Human GMF-β Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human GMF-β Market Size (2020-2031)
7.2 Europe Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Human GMF-β Market Size by Country (2020-2025)
7.4 Europe Recombinant Human GMF-β Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human GMF-β Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Human GMF-β Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Human GMF-β Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Human GMF-β Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human GMF-β Market Size (2020-2031)
9.2 Latin America Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Human GMF-β Market Size by Country (2020-2025)
9.4 Latin America Recombinant Human GMF-β Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human GMF-β Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Human GMF-β Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Human GMF-β Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Recombinant Human GMF-β Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Recombinant Human GMF-β Introduction
11.2.4 Bio-Techne Revenue in Recombinant Human GMF-β Business (2020-2025)
11.2.5 Bio-Techne Recent Development
11.3 Scientists Helping Scientists
11.3.1 Scientists Helping Scientists Company Details
11.3.2 Scientists Helping Scientists Business Overview
11.3.3 Scientists Helping Scientists Recombinant Human GMF-β Introduction
11.3.4 Scientists Helping Scientists Revenue in Recombinant Human GMF-β Business (2020-2025)
11.3.5 Scientists Helping Scientists Recent Development
11.4 Abcam Limited
11.4.1 Abcam Limited Company Details
11.4.2 Abcam Limited Business Overview
11.4.3 Abcam Limited Recombinant Human GMF-β Introduction
11.4.4 Abcam Limited Revenue in Recombinant Human GMF-β Business (2020-2025)
11.4.5 Abcam Limited Recent Development
11.5 FUJIFILM Irvine Scientific
11.5.1 FUJIFILM Irvine Scientific Company Details
11.5.2 FUJIFILM Irvine Scientific Business Overview
11.5.3 FUJIFILM Irvine Scientific Recombinant Human GMF-β Introduction
11.5.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human GMF-β Business (2020-2025)
11.5.5 FUJIFILM Irvine Scientific Recent Development
11.6 BD Biosciences
11.6.1 BD Biosciences Company Details
11.6.2 BD Biosciences Business Overview
11.6.3 BD Biosciences Recombinant Human GMF-β Introduction
11.6.4 BD Biosciences Revenue in Recombinant Human GMF-β Business (2020-2025)
11.6.5 BD Biosciences Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 BPS Bioscience, Inc.
11.8.1 BPS Bioscience, Inc. Company Details
11.8.2 BPS Bioscience, Inc. Business Overview
11.8.3 BPS Bioscience, Inc. Recombinant Human GMF-β Introduction
11.8.4 BPS Bioscience, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.8.5 BPS Bioscience, Inc. Recent Development
11.9 Elabscience
11.9.1 Elabscience Company Details
11.9.2 Elabscience Business Overview
11.9.3 Elabscience Recombinant Human GMF-β Introduction
11.9.4 Elabscience Revenue in Recombinant Human GMF-β Business (2020-2025)
11.9.5 Elabscience Recent Development
11.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
11.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details
11.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
11.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Introduction
11.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
11.11 Abbkine
11.11.1 Abbkine Company Details
11.11.2 Abbkine Business Overview
11.11.3 Abbkine Recombinant Human GMF-β Introduction
11.11.4 Abbkine Revenue in Recombinant Human GMF-β Business (2020-2025)
11.11.5 Abbkine Recent Development
11.12 Beijing Biocreative Technology Co., Ltd.
11.12.1 Beijing Biocreative Technology Co., Ltd. Company Details
11.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview
11.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Introduction
11.12.4 Beijing Biocreative Technology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development
11.13 Shanghai Yaji Biotechnology Co., Ltd.
11.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Details
11.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview
11.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Introduction
11.13.4 Shanghai Yaji Biotechnology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development
11.14 Cellverse Co., Ltd.
11.14.1 Cellverse Co., Ltd. Company Details
11.14.2 Cellverse Co., Ltd. Business Overview
11.14.3 Cellverse Co., Ltd. Recombinant Human GMF-β Introduction
11.14.4 Cellverse Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.14.5 Cellverse Co., Ltd. Recent Development
11.15 Dalian Meilun Biotech Co., Ltd.
11.15.1 Dalian Meilun Biotech Co., Ltd. Company Details
11.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview
11.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Introduction
11.15.4 Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development
11.16 Sino Biological,Inc.
11.16.1 Sino Biological,Inc. Company Details
11.16.2 Sino Biological,Inc. Business Overview
11.16.3 Sino Biological,Inc. Recombinant Human GMF-β Introduction
11.16.4 Sino Biological,Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.16.5 Sino Biological,Inc. Recent Development
11.17 Prospec-Tany Technogene Ltd
11.17.1 Prospec-Tany Technogene Ltd Company Details
11.17.2 Prospec-Tany Technogene Ltd Business Overview
11.17.3 Prospec-Tany Technogene Ltd Recombinant Human GMF-β Introduction
11.17.4 Prospec-Tany Technogene Ltd Revenue in Recombinant Human GMF-β Business (2020-2025)
11.17.5 Prospec-Tany Technogene Ltd Recent Development
11.18 ENZO
11.18.1 ENZO Company Details
11.18.2 ENZO Business Overview
11.18.3 ENZO Recombinant Human GMF-β Introduction
11.18.4 ENZO Revenue in Recombinant Human GMF-β Business (2020-2025)
11.18.5 ENZO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human GMF-β Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Market by Application
1.3.1 Global Recombinant Human GMF-β Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 University
1.3.3 Research Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human GMF-β Market Perspective (2020-2031)
2.2 Global Recombinant Human GMF-β Growth Trends by Region
2.2.1 Global Recombinant Human GMF-β Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Human GMF-β Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Human GMF-β Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Human GMF-β Market Dynamics
2.3.1 Recombinant Human GMF-β Industry Trends
2.3.2 Recombinant Human GMF-β Market Drivers
2.3.3 Recombinant Human GMF-β Market Challenges
2.3.4 Recombinant Human GMF-β Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human GMF-β Players by Revenue
3.1.1 Global Top Recombinant Human GMF-β Players by Revenue (2020-2025)
3.1.2 Global Recombinant Human GMF-β Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Human GMF-β Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human GMF-β Revenue
3.4 Global Recombinant Human GMF-β Market Concentration Ratio
3.4.1 Global Recombinant Human GMF-β Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human GMF-β Revenue in 2024
3.5 Global Key Players of Recombinant Human GMF-β Head office and Area Served
3.6 Global Key Players of Recombinant Human GMF-β, Product and Application
3.7 Global Key Players of Recombinant Human GMF-β, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human GMF-β Breakdown Data by Type
4.1 Global Recombinant Human GMF-β Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Human GMF-β Forecasted Market Size by Type (2026-2031)
5 Recombinant Human GMF-β Breakdown Data by Application
5.1 Global Recombinant Human GMF-β Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Human GMF-β Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Human GMF-β Market Size (2020-2031)
6.2 North America Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Human GMF-β Market Size by Country (2020-2025)
6.4 North America Recombinant Human GMF-β Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human GMF-β Market Size (2020-2031)
7.2 Europe Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Human GMF-β Market Size by Country (2020-2025)
7.4 Europe Recombinant Human GMF-β Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human GMF-β Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Human GMF-β Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Human GMF-β Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Human GMF-β Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human GMF-β Market Size (2020-2031)
9.2 Latin America Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Human GMF-β Market Size by Country (2020-2025)
9.4 Latin America Recombinant Human GMF-β Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human GMF-β Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Human GMF-β Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Human GMF-β Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Human GMF-β Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Recombinant Human GMF-β Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Recombinant Human GMF-β Introduction
11.2.4 Bio-Techne Revenue in Recombinant Human GMF-β Business (2020-2025)
11.2.5 Bio-Techne Recent Development
11.3 Scientists Helping Scientists
11.3.1 Scientists Helping Scientists Company Details
11.3.2 Scientists Helping Scientists Business Overview
11.3.3 Scientists Helping Scientists Recombinant Human GMF-β Introduction
11.3.4 Scientists Helping Scientists Revenue in Recombinant Human GMF-β Business (2020-2025)
11.3.5 Scientists Helping Scientists Recent Development
11.4 Abcam Limited
11.4.1 Abcam Limited Company Details
11.4.2 Abcam Limited Business Overview
11.4.3 Abcam Limited Recombinant Human GMF-β Introduction
11.4.4 Abcam Limited Revenue in Recombinant Human GMF-β Business (2020-2025)
11.4.5 Abcam Limited Recent Development
11.5 FUJIFILM Irvine Scientific
11.5.1 FUJIFILM Irvine Scientific Company Details
11.5.2 FUJIFILM Irvine Scientific Business Overview
11.5.3 FUJIFILM Irvine Scientific Recombinant Human GMF-β Introduction
11.5.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human GMF-β Business (2020-2025)
11.5.5 FUJIFILM Irvine Scientific Recent Development
11.6 BD Biosciences
11.6.1 BD Biosciences Company Details
11.6.2 BD Biosciences Business Overview
11.6.3 BD Biosciences Recombinant Human GMF-β Introduction
11.6.4 BD Biosciences Revenue in Recombinant Human GMF-β Business (2020-2025)
11.6.5 BD Biosciences Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 BPS Bioscience, Inc.
11.8.1 BPS Bioscience, Inc. Company Details
11.8.2 BPS Bioscience, Inc. Business Overview
11.8.3 BPS Bioscience, Inc. Recombinant Human GMF-β Introduction
11.8.4 BPS Bioscience, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.8.5 BPS Bioscience, Inc. Recent Development
11.9 Elabscience
11.9.1 Elabscience Company Details
11.9.2 Elabscience Business Overview
11.9.3 Elabscience Recombinant Human GMF-β Introduction
11.9.4 Elabscience Revenue in Recombinant Human GMF-β Business (2020-2025)
11.9.5 Elabscience Recent Development
11.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
11.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details
11.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
11.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Introduction
11.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
11.11 Abbkine
11.11.1 Abbkine Company Details
11.11.2 Abbkine Business Overview
11.11.3 Abbkine Recombinant Human GMF-β Introduction
11.11.4 Abbkine Revenue in Recombinant Human GMF-β Business (2020-2025)
11.11.5 Abbkine Recent Development
11.12 Beijing Biocreative Technology Co., Ltd.
11.12.1 Beijing Biocreative Technology Co., Ltd. Company Details
11.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview
11.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Introduction
11.12.4 Beijing Biocreative Technology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development
11.13 Shanghai Yaji Biotechnology Co., Ltd.
11.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Details
11.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview
11.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Introduction
11.13.4 Shanghai Yaji Biotechnology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development
11.14 Cellverse Co., Ltd.
11.14.1 Cellverse Co., Ltd. Company Details
11.14.2 Cellverse Co., Ltd. Business Overview
11.14.3 Cellverse Co., Ltd. Recombinant Human GMF-β Introduction
11.14.4 Cellverse Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.14.5 Cellverse Co., Ltd. Recent Development
11.15 Dalian Meilun Biotech Co., Ltd.
11.15.1 Dalian Meilun Biotech Co., Ltd. Company Details
11.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview
11.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Introduction
11.15.4 Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development
11.16 Sino Biological,Inc.
11.16.1 Sino Biological,Inc. Company Details
11.16.2 Sino Biological,Inc. Business Overview
11.16.3 Sino Biological,Inc. Recombinant Human GMF-β Introduction
11.16.4 Sino Biological,Inc. Revenue in Recombinant Human GMF-β Business (2020-2025)
11.16.5 Sino Biological,Inc. Recent Development
11.17 Prospec-Tany Technogene Ltd
11.17.1 Prospec-Tany Technogene Ltd Company Details
11.17.2 Prospec-Tany Technogene Ltd Business Overview
11.17.3 Prospec-Tany Technogene Ltd Recombinant Human GMF-β Introduction
11.17.4 Prospec-Tany Technogene Ltd Revenue in Recombinant Human GMF-β Business (2020-2025)
11.17.5 Prospec-Tany Technogene Ltd Recent Development
11.18 ENZO
11.18.1 ENZO Company Details
11.18.2 ENZO Business Overview
11.18.3 ENZO Recombinant Human GMF-β Introduction
11.18.4 ENZO Revenue in Recombinant Human GMF-β Business (2020-2025)
11.18.5 ENZO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human GMF-β Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Purity＜95%
Table 3. Key Players of Purity ≥95%
Table 4. Global Recombinant Human GMF-β Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant Human GMF-β Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant Human GMF-β Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant Human GMF-β Market Share by Region (2020-2025)
Table 8. Global Recombinant Human GMF-β Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant Human GMF-β Market Share by Region (2026-2031)
Table 10. Recombinant Human GMF-β Market Trends
Table 11. Recombinant Human GMF-β Market Drivers
Table 12. Recombinant Human GMF-β Market Challenges
Table 13. Recombinant Human GMF-β Market Restraints
Table 14. Global Recombinant Human GMF-β Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant Human GMF-β Market Share by Players (2020-2025)
Table 16. Global Top Recombinant Human GMF-β Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human GMF-β as of 2024)
Table 17. Ranking of Global Top Recombinant Human GMF-β Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant Human GMF-β Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant Human GMF-β, Headquarters and Area Served
Table 20. Global Key Players of Recombinant Human GMF-β, Product and Application
Table 21. Global Key Players of Recombinant Human GMF-β, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Human GMF-β Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant Human GMF-β Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant Human GMF-β Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant Human GMF-β Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant Human GMF-β Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant Human GMF-β Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant Human GMF-β Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant Human GMF-β Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant Human GMF-β Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant Human GMF-β Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant Human GMF-β Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Scientific Inc. Company Details
Table 47. Thermo Fisher Scientific Inc. Business Overview
Table 48. Thermo Fisher Scientific Inc. Recombinant Human GMF-β Product
Table 49. Thermo Fisher Scientific Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Scientific Inc. Recent Development
Table 51. Bio-Techne Company Details
Table 52. Bio-Techne Business Overview
Table 53. Bio-Techne Recombinant Human GMF-β Product
Table 54. Bio-Techne Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Recent Development
Table 56. Scientists Helping Scientists Company Details
Table 57. Scientists Helping Scientists Business Overview
Table 58. Scientists Helping Scientists Recombinant Human GMF-β Product
Table 59. Scientists Helping Scientists Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 60. Scientists Helping Scientists Recent Development
Table 61. Abcam Limited Company Details
Table 62. Abcam Limited Business Overview
Table 63. Abcam Limited Recombinant Human GMF-β Product
Table 64. Abcam Limited Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 65. Abcam Limited Recent Development
Table 66. FUJIFILM Irvine Scientific Company Details
Table 67. FUJIFILM Irvine Scientific Business Overview
Table 68. FUJIFILM Irvine Scientific Recombinant Human GMF-β Product
Table 69. FUJIFILM Irvine Scientific Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 70. FUJIFILM Irvine Scientific Recent Development
Table 71. BD Biosciences Company Details
Table 72. BD Biosciences Business Overview
Table 73. BD Biosciences Recombinant Human GMF-β Product
Table 74. BD Biosciences Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 75. BD Biosciences Recent Development
Table 76. Bio-Rad Laboratories, Inc. Company Details
Table 77. Bio-Rad Laboratories, Inc. Business Overview
Table 78. Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Product
Table 79. Bio-Rad Laboratories, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Laboratories, Inc. Recent Development
Table 81. BPS Bioscience, Inc. Company Details
Table 82. BPS Bioscience, Inc. Business Overview
Table 83. BPS Bioscience, Inc. Recombinant Human GMF-β Product
Table 84. BPS Bioscience, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 85. BPS Bioscience, Inc. Recent Development
Table 86. Elabscience Company Details
Table 87. Elabscience Business Overview
Table 88. Elabscience Recombinant Human GMF-β Product
Table 89. Elabscience Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 90. Elabscience Recent Development
Table 91. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details
Table 92. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
Table 93. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Product
Table 94. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 95. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
Table 96. Abbkine Company Details
Table 97. Abbkine Business Overview
Table 98. Abbkine Recombinant Human GMF-β Product
Table 99. Abbkine Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 100. Abbkine Recent Development
Table 101. Beijing Biocreative Technology Co., Ltd. Company Details
Table 102. Beijing Biocreative Technology Co., Ltd. Business Overview
Table 103. Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Product
Table 104. Beijing Biocreative Technology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 105. Beijing Biocreative Technology Co., Ltd. Recent Development
Table 106. Shanghai Yaji Biotechnology Co., Ltd. Company Details
Table 107. Shanghai Yaji Biotechnology Co., Ltd. Business Overview
Table 108. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Product
Table 109. Shanghai Yaji Biotechnology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 110. Shanghai Yaji Biotechnology Co., Ltd. Recent Development
Table 111. Cellverse Co., Ltd. Company Details
Table 112. Cellverse Co., Ltd. Business Overview
Table 113. Cellverse Co., Ltd. Recombinant Human GMF-β Product
Table 114. Cellverse Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 115. Cellverse Co., Ltd. Recent Development
Table 116. Dalian Meilun Biotech Co., Ltd. Company Details
Table 117. Dalian Meilun Biotech Co., Ltd. Business Overview
Table 118. Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Product
Table 119. Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 120. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 121. Sino Biological,Inc. Company Details
Table 122. Sino Biological,Inc. Business Overview
Table 123. Sino Biological,Inc. Recombinant Human GMF-β Product
Table 124. Sino Biological,Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 125. Sino Biological,Inc. Recent Development
Table 126. Prospec-Tany Technogene Ltd Company Details
Table 127. Prospec-Tany Technogene Ltd Business Overview
Table 128. Prospec-Tany Technogene Ltd Recombinant Human GMF-β Product
Table 129. Prospec-Tany Technogene Ltd Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 130. Prospec-Tany Technogene Ltd Recent Development
Table 131. ENZO Company Details
Table 132. ENZO Business Overview
Table 133. ENZO Recombinant Human GMF-β Product
Table 134. ENZO Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 135. ENZO Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Recombinant Human GMF-β Picture
Figure 2. Global Recombinant Human GMF-β Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human GMF-β Market Share by Type: 2024 VS 2031
Figure 4. Purity＜95% Features
Figure 5. Purity ≥95% Features
Figure 6. Global Recombinant Human GMF-β Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human GMF-β Market Share by Application: 2024 VS 2031
Figure 8. University Case Studies
Figure 9. Research Center Case Studies
Figure 10. Recombinant Human GMF-β Report Years Considered
Figure 11. Global Recombinant Human GMF-β Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Recombinant Human GMF-β Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Recombinant Human GMF-β Market Share by Region: 2024 VS 2031
Figure 14. Global Recombinant Human GMF-β Market Share by Players in 2024
Figure 15. Global Recombinant Human GMF-β Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human GMF-β Revenue in 2024
Figure 17. North America Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 19. United States Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 23. Germany Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Human GMF-β Market Share by Region (2020-2031)
Figure 31. China Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 39. Mexico Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 43. Turkey Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 47. Bio-Techne Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 48. Scientists Helping Scientists Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 49. Abcam Limited Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 50. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 51. BD Biosciences Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 53. BPS Bioscience, Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 54. Elabscience Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 55. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 56. Abbkine Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 57. Beijing Biocreative Technology Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 58. Shanghai Yaji Biotechnology Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 59. Cellverse Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 60. Dalian Meilun Biotech Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 61. Sino Biological,Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 62. Prospec-Tany Technogene Ltd Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 63. ENZO Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Recombinant Human GMF-β Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Purity＜95%
Table 3. Key Players of Purity ≥95%
Table 4. Global Recombinant Human GMF-β Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant Human GMF-β Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant Human GMF-β Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant Human GMF-β Market Share by Region (2020-2025)
Table 8. Global Recombinant Human GMF-β Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant Human GMF-β Market Share by Region (2026-2031)
Table 10. Recombinant Human GMF-β Market Trends
Table 11. Recombinant Human GMF-β Market Drivers
Table 12. Recombinant Human GMF-β Market Challenges
Table 13. Recombinant Human GMF-β Market Restraints
Table 14. Global Recombinant Human GMF-β Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant Human GMF-β Market Share by Players (2020-2025)
Table 16. Global Top Recombinant Human GMF-β Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human GMF-β as of 2024)
Table 17. Ranking of Global Top Recombinant Human GMF-β Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant Human GMF-β Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant Human GMF-β, Headquarters and Area Served
Table 20. Global Key Players of Recombinant Human GMF-β, Product and Application
Table 21. Global Key Players of Recombinant Human GMF-β, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Human GMF-β Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant Human GMF-β Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant Human GMF-β Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant Human GMF-β Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant Human GMF-β Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant Human GMF-β Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant Human GMF-β Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant Human GMF-β Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant Human GMF-β Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant Human GMF-β Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant Human GMF-β Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant Human GMF-β Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant Human GMF-β Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human GMF-β Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Scientific Inc. Company Details
Table 47. Thermo Fisher Scientific Inc. Business Overview
Table 48. Thermo Fisher Scientific Inc. Recombinant Human GMF-β Product
Table 49. Thermo Fisher Scientific Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Scientific Inc. Recent Development
Table 51. Bio-Techne Company Details
Table 52. Bio-Techne Business Overview
Table 53. Bio-Techne Recombinant Human GMF-β Product
Table 54. Bio-Techne Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Recent Development
Table 56. Scientists Helping Scientists Company Details
Table 57. Scientists Helping Scientists Business Overview
Table 58. Scientists Helping Scientists Recombinant Human GMF-β Product
Table 59. Scientists Helping Scientists Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 60. Scientists Helping Scientists Recent Development
Table 61. Abcam Limited Company Details
Table 62. Abcam Limited Business Overview
Table 63. Abcam Limited Recombinant Human GMF-β Product
Table 64. Abcam Limited Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 65. Abcam Limited Recent Development
Table 66. FUJIFILM Irvine Scientific Company Details
Table 67. FUJIFILM Irvine Scientific Business Overview
Table 68. FUJIFILM Irvine Scientific Recombinant Human GMF-β Product
Table 69. FUJIFILM Irvine Scientific Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 70. FUJIFILM Irvine Scientific Recent Development
Table 71. BD Biosciences Company Details
Table 72. BD Biosciences Business Overview
Table 73. BD Biosciences Recombinant Human GMF-β Product
Table 74. BD Biosciences Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 75. BD Biosciences Recent Development
Table 76. Bio-Rad Laboratories, Inc. Company Details
Table 77. Bio-Rad Laboratories, Inc. Business Overview
Table 78. Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Product
Table 79. Bio-Rad Laboratories, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Laboratories, Inc. Recent Development
Table 81. BPS Bioscience, Inc. Company Details
Table 82. BPS Bioscience, Inc. Business Overview
Table 83. BPS Bioscience, Inc. Recombinant Human GMF-β Product
Table 84. BPS Bioscience, Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 85. BPS Bioscience, Inc. Recent Development
Table 86. Elabscience Company Details
Table 87. Elabscience Business Overview
Table 88. Elabscience Recombinant Human GMF-β Product
Table 89. Elabscience Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 90. Elabscience Recent Development
Table 91. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details
Table 92. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
Table 93. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Product
Table 94. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 95. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
Table 96. Abbkine Company Details
Table 97. Abbkine Business Overview
Table 98. Abbkine Recombinant Human GMF-β Product
Table 99. Abbkine Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 100. Abbkine Recent Development
Table 101. Beijing Biocreative Technology Co., Ltd. Company Details
Table 102. Beijing Biocreative Technology Co., Ltd. Business Overview
Table 103. Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Product
Table 104. Beijing Biocreative Technology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 105. Beijing Biocreative Technology Co., Ltd. Recent Development
Table 106. Shanghai Yaji Biotechnology Co., Ltd. Company Details
Table 107. Shanghai Yaji Biotechnology Co., Ltd. Business Overview
Table 108. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Product
Table 109. Shanghai Yaji Biotechnology Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 110. Shanghai Yaji Biotechnology Co., Ltd. Recent Development
Table 111. Cellverse Co., Ltd. Company Details
Table 112. Cellverse Co., Ltd. Business Overview
Table 113. Cellverse Co., Ltd. Recombinant Human GMF-β Product
Table 114. Cellverse Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 115. Cellverse Co., Ltd. Recent Development
Table 116. Dalian Meilun Biotech Co., Ltd. Company Details
Table 117. Dalian Meilun Biotech Co., Ltd. Business Overview
Table 118. Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Product
Table 119. Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 120. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 121. Sino Biological,Inc. Company Details
Table 122. Sino Biological,Inc. Business Overview
Table 123. Sino Biological,Inc. Recombinant Human GMF-β Product
Table 124. Sino Biological,Inc. Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 125. Sino Biological,Inc. Recent Development
Table 126. Prospec-Tany Technogene Ltd Company Details
Table 127. Prospec-Tany Technogene Ltd Business Overview
Table 128. Prospec-Tany Technogene Ltd Recombinant Human GMF-β Product
Table 129. Prospec-Tany Technogene Ltd Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 130. Prospec-Tany Technogene Ltd Recent Development
Table 131. ENZO Company Details
Table 132. ENZO Business Overview
Table 133. ENZO Recombinant Human GMF-β Product
Table 134. ENZO Revenue in Recombinant Human GMF-β Business (2020-2025) & (US$ Million)
Table 135. ENZO Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Recombinant Human GMF-β Picture
Figure 2. Global Recombinant Human GMF-β Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human GMF-β Market Share by Type: 2024 VS 2031
Figure 4. Purity＜95% Features
Figure 5. Purity ≥95% Features
Figure 6. Global Recombinant Human GMF-β Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human GMF-β Market Share by Application: 2024 VS 2031
Figure 8. University Case Studies
Figure 9. Research Center Case Studies
Figure 10. Recombinant Human GMF-β Report Years Considered
Figure 11. Global Recombinant Human GMF-β Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Recombinant Human GMF-β Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Recombinant Human GMF-β Market Share by Region: 2024 VS 2031
Figure 14. Global Recombinant Human GMF-β Market Share by Players in 2024
Figure 15. Global Recombinant Human GMF-β Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human GMF-β Revenue in 2024
Figure 17. North America Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 19. United States Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 23. Germany Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Human GMF-β Market Share by Region (2020-2031)
Figure 31. China Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 39. Mexico Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Human GMF-β Market Share by Country (2020-2031)
Figure 43. Turkey Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Recombinant Human GMF-β Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 47. Bio-Techne Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 48. Scientists Helping Scientists Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 49. Abcam Limited Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 50. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 51. BD Biosciences Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 53. BPS Bioscience, Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 54. Elabscience Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 55. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 56. Abbkine Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 57. Beijing Biocreative Technology Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 58. Shanghai Yaji Biotechnology Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 59. Cellverse Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 60. Dalian Meilun Biotech Co., Ltd. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 61. Sino Biological,Inc. Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 62. Prospec-Tany Technogene Ltd Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 63. ENZO Revenue Growth Rate in Recombinant Human GMF-β Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232